Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Research Abstract |
BH3 profilings for CD4 positive regulatory (Treg) and non regulatory (Tcon) T cells were examined. Different priming between Treg and Tcon was associated to the effect of IL-2, especially on Treg, which contributes to cell survival. This profiling can explain how low dose IL-2 therapy works in patients with chronic graft-versus-host disease.
|